Literature DB >> 22752725

Correlation between serum CA724 and gastric cancer: multiple analyses based on Chinese population.

Xin-Zu Chen1, Wei-Ke Zhang, Kun Yang, Lan-Lan Wang, Jin Liu, Li Wang, Jian-Kun Hu, Bo Zhang, Zhi-Xin Chen, Jia-Ping Chen, Zong-Guang Zhou, Xian-Ming Mo.   

Abstract

Serum tumor biomarker carbohydrate antigen 724 (CA724) is noticeable for gastric cancer. Correlation between CA724 and gastric cancer was investigated based on Chinese population. Chinese Biomedical Database, Chinese Journal Full-text Database and PubMed were searched. Gastric cancer patients were proven by biopsy, and control included health volunteers or benign gastric diseases. Participants received at least one test of CA724, CA125, CA153, CA199, CA242 or CEA. Meta-analysis, summary ROC (SROC) and post hoc analysis were performed by RevMan 5.0 and SPSS 11.5. Totally, 33 eligible studies were analyzed. Meta-analysis showed CA724 had the highest odds ratio 32.86 compared to control, orderly followed by CA242, CA199, CEA, CA125 and CA153. Accumulated accuracy rate of CA724 was 77 %, superior to others. In SROC analysis, specificity of all studies was above 0.70, but sensitivity of few studies was above 0.70; CA724 was selected as the preferable single test, followed by CA242, CA199, CEA, CA125 and CA153. If threshold of both specificity and sensitivity up to 0.70, CA153 was unacceptable; if up to 0.80, only CA724 and CA242 were considerable. In CA724-combined patterns, CA724+CEA+CA199 combination performed best by increasing sensitivity to 0.74 without impairing specificity, while CA724 + CA199 pattern was not a proper combination. CA724 was the most correlative serum tumor biomarker for gastric cancer in Chinese population. Sensitivity of serum CA724 is limited, but CA724+CEA+CA199 combination is considerable to improve sensitivity without impairing specificity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22752725     DOI: 10.1007/s11033-012-1774-x

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  21 in total

1.  The prognostic significance of preoperative serum CA 19-9 in patients with resectable gastric carcinoma: comparison with CEA.

Authors:  N Duraker; A N Celik
Journal:  J Surg Oncol       Date:  2001-04       Impact factor: 3.454

Review 2.  Meta-analysis of effectiveness and safety of D2 plus para-aortic lymphadenectomy for resectable gastric cancer.

Authors:  Xin-Zu Chen; Jian-Kun Hu; Zong-Guang Zhou; Yuan-Yi Rui; Kun Yang; Li Wang; Bo Zhang; Zhi-Xin Chen; Jia-Ping Chen
Journal:  J Am Coll Surg       Date:  2009-11-04       Impact factor: 6.113

3.  Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world.

Authors:  Farin Kamangar; Graça M Dores; William F Anderson
Journal:  J Clin Oncol       Date:  2006-05-10       Impact factor: 44.544

4.  Neoadjuvant plus adjuvant chemotherapy benefits overall survival of locally advanced gastric cancer.

Authors:  Xin-Zu Chen; Kun Yang; Jie Liu; Xiao-Long Chen; Jian-Kun Hu
Journal:  World J Gastroenterol       Date:  2011-10-28       Impact factor: 5.742

5.  Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma.

Authors:  M J Gaspar; I Arribas; M C Coca; M Díez-Alonso
Journal:  Tumour Biol       Date:  2001 Sep-Oct

6.  Estimating diagnostic accuracy from multiple conflicting reports: a new meta-analytic method.

Authors:  B Littenberg; L E Moses
Journal:  Med Decis Making       Date:  1993 Oct-Dec       Impact factor: 2.583

7.  Adjuvant 5-fluorouracil plus doxorubicin in D2-3 resected gastric carcinoma: 15-year experience at a single institute.

Authors:  H C Jeung; S Y Rha; S H Noh; J S Min; B S Kim; H C Chung
Journal:  Cancer       Date:  2001-06-01       Impact factor: 6.860

8.  Short-term evaluation of laparoscopy-assisted distal gastrectomy for predictive early gastric cancer: a meta-analysis of randomized controlled trials.

Authors:  Xin-Zu Chen; Jian-Kun Hu; Kun Yang; Li Wang; Qing-Chun Lu
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2009-08       Impact factor: 1.719

Review 9.  Epidemiology of gastric cancer.

Authors:  Katherine D Crew; Alfred I Neugut
Journal:  World J Gastroenterol       Date:  2006-01-21       Impact factor: 5.742

10.  Preoperative hCGbeta and CA 72-4 are prognostic factors in gastric cancer.

Authors:  Johanna Louhimo; Arto Kokkola; Henrik Alfthan; Ulf-Håkan Stenman; Caj Haglund
Journal:  Int J Cancer       Date:  2004-10-10       Impact factor: 7.396

View more
  48 in total

1.  Prognostic value of carbohydrate tumor markers and inflammation-based markers in metastatic or recurrent gastric cancer.

Authors:  Qing Wang; Yang Yang; Ya-Ping Zhang; Zhengyun Zou; Xiaoping Qian; Baorui Liu; Jia Wei
Journal:  Med Oncol       Date:  2014-10-26       Impact factor: 3.064

2.  Prognostic and clinical significance of STAT3 and MMP9 in patients with gastric cancer: a meta-analysis of a Chinese cohort.

Authors:  Jing Chen; Xiaoxia Liu; Haiyan Jiao; Liang Peng; Zhenghao Huo; Wenjun Yang; Qin Shen; Tao Li; Qilun Liu
Journal:  Int J Clin Exp Med       Date:  2015-01-15

3.  Decline of serum CA724 as a probable predictive factor for tumor response during chemotherapy of advanced gastric carcinoma.

Authors:  Li Zou; Jun Qian
Journal:  Chin J Cancer Res       Date:  2014-08       Impact factor: 5.087

4.  Quantitative comparisons of summary receiver operating characteristics (sROC) curves among conventional serological tumor biomarkers for predicting gastric cancer in Chinese population.

Authors:  Xin-Zu Chen; Wei-Han Zhang; Kun Yang; Bo Zhang; Zhi-Xin Chen; Jia-Ping Chen; Zong-Guang Zhou; Jian-Kun Hu
Journal:  Tumour Biol       Date:  2014-06-07

5.  Biological variation of serum neuron-specific enolase and carbohydrate antigen 724 tumor markers.

Authors:  Shuo Wang; Min Zhao; Runqing Mu; Xin Zhang; Ke Yun; Hong Shang
Journal:  J Clin Lab Anal       Date:  2017-09-19       Impact factor: 2.352

6.  Detection of perioperative cancer antigen 72-4 in gastric juice pre- and post-distal gastrectomy and its significances.

Authors:  Lei Huang; Aman Xu; Tuanjie Li; Wenxiu Han; Shanshan Wu; Yangyi Wang
Journal:  Med Oncol       Date:  2013-07-03       Impact factor: 3.064

7.  Prediction of peritoneal recurrence by the mRNA level of CEA and MMP-7 in peritoneal lavage of gastric cancer patients.

Authors:  Zhen Li; Dewei Zhang; Hao Zhang; Zhifeng Miao; Yuanxin Tang; Gongping Sun; Dongqiu Dai
Journal:  Tumour Biol       Date:  2013-11-27

8.  Differences and correlation of serum CEA, CA19-9 and CA72-4 in gastric cancer.

Authors:  Junxiu Yu; Shuguang Zhang; Bingbo Zhao
Journal:  Mol Clin Oncol       Date:  2015-12-15

9.  Levels of CEA, CA153, CA199, CA724 and AFP in nipple discharge of breast cancer patients.

Authors:  Song Zhao; Yu Mei; Yongmei Wang; Jiang Zhu; Guixi Zheng; Rong Ma
Journal:  Int J Clin Exp Med       Date:  2015-11-15

Review 10.  Clinical significance of serum tumor markers for gastric cancer: a systematic review of literature by the Task Force of the Japanese Gastric Cancer Association.

Authors:  Hideaki Shimada; Tamaki Noie; Manabu Ohashi; Koji Oba; Yutaka Takahashi
Journal:  Gastric Cancer       Date:  2013-04-10       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.